TABLE 3

Kinetic parameters for norverapamil formation in hepatic or intestinal microsomes of control and diabetic rats

n = 4. Subscripts 1 and 2 denote the high- and low-affinity components of the reaction, respectively.

ParametersControl RatsDiabetic Rats
Hepatic microsomes
    Vmax (nmol/min per mg of protein)1.60 ± 0.302.38 ± 0.32*
    Km (μM)13.21 ± 1.9716.09 ± 2.32
    CLint (ml/min per mg of protein)0.122 ± 0.0160.149 ± 0.015*
    CLint (ml/min per g of liver)1.110 ± 0.2731.261 ± 0.206
Intestinal microsomes
    Vmax, 1 (pmol/min per mg of protein)49.04 ± 15.7822.70 ± 5.07*
    Km, 1 (μM)34.06 ± 5.1955.37 ± 22.22
    CLint, 1 (μl/min per mg of protein)1.42 ± 0.280.43 ± 0.08**
    Vmax, 2 (pmol/min per mg of protein)122.41 ± 32.04139.23 ± 10.75
    Km, 2 (μM)1041.37 ± 88.471388.66 ± 157.69*
    CLint, 2 (μl/min per mg of protein)0.12 ± 0.040.10 ± 0.02
    Total CLint (μl/min per mg of protein)1.54 ± 0.240.53 ± 0.10**
    Total CLint (μl/min per g of intestinal mucosa)5.382 ± 1.1061.130 ± 0.235**
  • * p < 0.05.

  • ** p < 0.01 versus control rats.